Prognostic roles of hematological indicators in programmed cell death protein 1/programmed cell death ligand 1 inhibitors for small-cell lung cancer: a retrospective cohort study.
Du J, Zhang Q, Tian L, Chen Y, Tian Y, Dempke WCM, Arasanz H, Soo RA, Zhou Z, Meng Q, Liu Y.
Du J, et al.
J Thorac Dis. 2024 Dec 31;16(12):8669-8683. doi: 10.21037/jtd-24-1826. Epub 2024 Dec 28.
J Thorac Dis. 2024.
PMID: 39831216
Free PMC article.
As of 1st March 2023, all patients had received a post-diagnosis follow-up. The median follow-up time was 11.7 months. RESULTS: Among the 246 patients with SCLC receiving PD-1/PD-L1 inhibitor treatment. the overall response rate and disease control rate were 47.6% and 89.8 …
As of 1st March 2023, all patients had received a post-diagnosis follow-up. The median follow-up time was 11.7 months. RESULTS: Among …